TOWA PHARMACEUTICAL CO.,LTD. Logo

TOWA PHARMACEUTICAL CO.,LTD.

Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.

4553 | T

Overview

Corporate Details

ISIN(s):
JP3623150004
LEI:
Country:
Japan
Address:
門真市新橋町2番11号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TOWA PHARMACEUTICAL CO.,LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and marketing of generic drugs. Founded in 1951, the company is dedicated to providing high-quality and accessible medications. Its product portfolio encompasses a wide range of therapeutic areas, including drugs for the nervous system, digestive system, and allergic diseases, in addition to vitamins and antibiotics. The company focuses on formulation development to enhance its product offerings and contributes to healthcare by making essential medicines more widely available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 01:01
Registration Form
確認書
Japanese 8.1 KB
2025-11-11 01:00
Interim Report
半期報告書-第70期(2025/04/01-2026/03/31)
Japanese 206.2 KB
2025-06-27 08:01
Post-Annual General Meeting Information
臨時報告書
Japanese 24.0 KB
2025-06-24 05:01
Governance Information
内部統制報告書-第69期(2024/04/01-2025/03/31)
Japanese 23.6 KB
2025-06-24 05:00
Annual Report
有価証券報告書-第69期(2024/04/01-2025/03/31)
Japanese 1.4 MB
2025-06-24 05:00
Registration Form
確認書
Japanese 8.1 KB
2024-11-13 01:01
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-13 01:00
Interim Report
半期報告書-第69期(2024/04/01-2025/03/31)
Japanese 207.6 KB
2024-07-10 09:04
Registration Form
確認書
Japanese 8.1 KB
2024-07-10 09:00
Annual Report
訂正有価証券報告書-第68期(2023/04/01-2024/03/31)
Japanese 849.4 KB
2024-06-27 05:54
Post-Annual General Meeting Information
臨時報告書
Japanese 24.9 KB
2024-06-26 02:02
Governance Information
内部統制報告書-第68期(2023/04/01-2024/03/31)
Japanese 21.7 KB
2024-06-26 02:01
Registration Form
確認書
Japanese 8.1 KB
2024-06-26 02:01
Annual Report
有価証券報告書-第68期(2023/04/01-2024/03/31)
Japanese 1.4 MB
2024-02-14 01:01
Report Publication Announcement
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all TOWA PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TOWA PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TOWA PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom
HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom
HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea
376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland
HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland
HRTIS
HERON THERAPEUTICS, INC. /DE/ Logo
Develops and commercializes therapies for acute care and oncology to manage pain and nausea.
United States of America
HRTX
Global manufacturer of carbapenem antibiotic APIs for regulated markets.
South Korea
106190
HIKMA Pharmaceuticals PLC Logo
Develops & markets affordable generic & specialty medicines for markets in NA, MENA, & Europe.
United Kingdom
HIK
HISAMITSU PHARMACEUTICAL CO.,INC. Logo
A global leader in transdermal drug delivery systems for OTC and prescription pain relief.
Japan
4530
HLB Genex, Inc. Logo
Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.
South Korea
187420

Talk to a Data Expert

Have a question? We'll get back to you promptly.